Statements (62)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:physicist
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:Enterococcus
|
gptkbp:caused_by |
infections
|
gptkbp:has_role |
gut microbiota
|
https://www.w3.org/2000/01/rdf-schema#label |
Enterococcus faecium
|
gptkbp:is_associated_with |
sepsis
hospital-acquired infections chronic infections urinary tract infections endocarditis bacteremia wound infections diarrheal diseases |
gptkbp:is_characterized_by |
catalase negativity
|
gptkbp:is_considered_as |
opportunistic pathogen
|
gptkbp:is_found_in |
gptkb:garden
gptkb:product biofilms fermented vegetables human gut human saliva animal intestines probiotic supplements |
gptkbp:is_known_for |
antibiotic resistance
biofilm formation its role in food fermentation its ability to survive in harsh conditions high-level aminoglycoside resistance its genetic adaptability |
gptkbp:is_often_depicted_as |
fecal matter
|
gptkbp:is_part_of |
intestinal microbiota
microbiome human microbiome normal flora clinical microbiology studies food microbiology research Enterococcus genus clinical guidelines for infection control |
gptkbp:is_recognized_by |
Gram staining
|
gptkbp:is_related_to |
gptkb:Enterococcus_faecalis
|
gptkbp:is_studied_in |
its ecological impact
its metabolic pathways medical microbiology its genetic diversity its virulence factors its role in antibiotic resistance its role in gut health its interactions with other bacteria |
gptkbp:is_used_in |
gptkb:Company
fermented foods probiotics probiotic formulations |
gptkbp:is_vulnerable_to |
gptkb:ampicillin
gptkb:chloramphenicol gptkb:rifampicin gptkb:tetracycline gentamicin many antibiotics quinupristin-dalfopristin |
gptkbp:sensor |
vancomycin
|
gptkbp:treatment |
linezolid
|